J Ludvigsson, M Faresjo, M Hjorth, S … - The New England …, 2008 - nejm.highwire.org Results Insulin secretion gradually decreased in both study groups. The study treatment had
no significant effect on change in fasting C-peptide level after 15 months (the primary end
point). Fasting C-peptide levels declined from baseline levels significantly less over 30 ... Cited by 32 - Related articles - All 7 versions
J Ludvigsson - Diabetes/Metabolism Research and Reviews, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 2 versions
KC Herold, S Gitelman, C Greenbaum, J Puck, W … - Clinical Immunology, 2009 - Elsevier Anti-CD3 mAbs may prolong β cell function up to 2 years in patients with new onset Type 1 diabetes
(T1DM). A randomized open label trial of anti-CD3 mAb, Teplizumab, in T1DM was stopped after
10 subjects because of increased adverse events than in a previous trial related with ... Cited by 2 - Related articles - All 2 versions
[CITATION] Challenges in developing endpoints for type 1 diabetes intervention studies …
S Cernea, I Raz, KC Herold, B … - Diabetes/ …, 2009 - John Wiley & Sons, Ltd. Chichester, …
E Vandemeulebroucke, B Keymeulen, K Decochez, I … - Diabetologia - Springer Abstract Aims/hypothesis The aim of the study was to investigate the use of hyperglycaemic clamp
tests to identify individuals who will develop diabetes among insulinoma-associated
protein-2 antibody (IA-2A)-positive first-degree relatives (IA-2A+ FDRs) of type 1 diabetic ...
J Ludvigsson - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
KM Dungan, JB Buse, RE Ratner - … /Metabolism Research and …, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 2 versions